|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.9 USD | +1.04% |
|
+20.74% | -15.22% |
| 05-14 | Transcript : NRx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-06 | NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data | DJ |
On May 19, 2022, Mr. Ira Strassberg tendered his resignation as Chief Financial Officer of NRx Pharmaceuticals, Inc. effective July 18, 2022. Mr. Strassberg is leaving the Company to pursue other personal and professional interests. Mr. Strassberg will continue to fulfill his duties as Chief Financial Officer of the Company until his departure.
The Board will be conducting a search for a successor.
| 1st Jan change | Capi. | |
|---|---|---|
| -15.22% | 40.23M | |
| +64.23% | 55.07B | |
| -2.31% | 41.79B | |
| +44.36% | 40.22B | |
| -8.29% | 28.17B | |
| +11.97% | 26.28B | |
| -21.16% | 18.93B | |
| +7.54% | 13.03B | |
| +27.17% | 12.26B | |
| +25.72% | 12.21B |
NRX PHARMACEUTICALS, INC. 
